Clinical Trials on Myocardial Fibrosis
Total 15243 results
-
University of AarhusEurostarsUnknownFeasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) (3-IPF)Idiopathic Pulmonary FibrosisDenmark
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisCanada, United States, Netherlands, France, Italy, Germany
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisGermany, United Kingdom, Ireland, France, Austria, Denmark, Finland, Italy, Norway, Sweden
-
Genentech, Inc.CompletedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheInterMune Deutschland GmbHCompletedIdiopathic Pulmonary FibrosisGermany
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Genentech, Inc.Approved for marketingIdiopathic Pulmonary Fibrosis
-
Genzyme, a Sanofi CompanyCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium
-
US Department of Veterans AffairsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research InstituteTerminatedIdiopathic Pulmonary FibrosisUnited States
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Institut National de la Santé Et de la Recherche...CompletedIdiopathic Pulmonary Fibrosis
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Switzerland, Israel, Canada, France, Germany, Italy
-
Rabin Medical CenterUnknownIdiopathic Pulmonary FibrosisIsrael
-
InterMuneCompletedIdiopathic Pulmonary FibrosisUnited States
-
Marmara UniversityCompletedPulmonary Fibrosis, IdiopathicTurkey
-
Flinders UniversityNot yet recruitingDilated Cardiomyopathy | Left Ventricular Systolic Dysfunction | Fibrosis Myocardial
-
4D Molecular TherapeuticsRecruiting
-
Manchester University NHS Foundation TrustUniversity of Nottingham; University of Manchester; Innovate UKRecruitingAlcoholic Liver Disease | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Liver FibrosesUnited Kingdom
-
Hospices Civils de LyonRecruitingProgressive Idiopathic Pulmonary FibrosisFrance
-
Jianwu DaiSouthwest Hospital, ChinaCompletedPost-radiotherapy Pulmonary FibrosisChina
-
Imperial College LondonNational Institute for Health Research, United Kingdom; Imperial College Healthcare...WithdrawnMyocardial Fibrosis | Heart Failure | End Stage Renal Failure on Dialysis | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe)United Kingdom
-
University Hospital, GrenobleUnknownCystic Fibrosis Pulmonary ExacerbationFrance
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of TorontoTerminatedCystic Fibrosis Pulmonary ExacerbationCanada
-
AmMax Bio, Inc.Withdrawn
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, United Kingdom
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); Brown UniversityCompleted
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)WithdrawnHealthy | Idiopathic Pulmonary FibrosisUnited States
-
University of MichiganCoalition for Pulmonary FibrosisCompletedIdiopathic Pulmonary FibrosisUnited States
-
Aljazeera HospitalCairo UniversityCompleted
-
Cedars-Sinai Medical CenterGenentech, Inc.Recruiting
-
Blade TherapeuticsNot yet recruitingRESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis
-
University Hospital, ToursInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingIdiopathic Pulmonary FibrosisFrance
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, Germany, Italy, Canada, Ireland, United Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisGreece
-
Assistance Publique - Hôpitaux de ParisCompletedIdiopathic Pulmonary FibrosisFrance
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Italy, Germany, Switzerland, Czechia, Spain
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Belgium, Australia, United Kingdom, Canada, China, Germany, Japan, Turkey, France, Ireland, Italy, Israel, Netherlands, Portugal, Greece, India, Czechia, Chile, Finland, Mexico, Russian Federation
-
Belgian Thoracic SocietyBoehringer Ingelheim; Roche Farma, S.ACompletedIdiopathic Pulmonary FibrosisBelgium, Luxembourg
-
Institut d'Investigació Biomèdica de BellvitgeCompleted
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States